X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2149) 2149
Publication (351) 351
Book Review (333) 333
Conference Proceeding (31) 31
Book Chapter (26) 26
Magazine Article (6) 6
Dissertation (5) 5
Book / eBook (1) 1
Government Document (1) 1
Reference (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
varenicline (1922) 1922
index medicus (1377) 1377
humans (1300) 1300
smoking cessation (941) 941
male (833) 833
smoking cessation - methods (761) 761
female (731) 731
adult (593) 593
smoking (580) 580
middle aged (539) 539
nicotine (520) 520
receptor partial agonist (509) 509
benzazepines - therapeutic use (502) 502
quinoxalines - therapeutic use (496) 496
nicotinic agonists - therapeutic use (483) 483
smoking-cessation (450) 450
psychiatry (435) 435
pharmacology & pharmacy (429) 429
sustained-release bupropion (427) 427
smoking cessation programs (424) 424
treatment outcome (365) 365
bupropion (363) 363
substance abuse (339) 339
tobacco (329) 329
smokers (322) 322
nicotine replacement therapy (319) 319
randomized controlled-trial (306) 306
benzazepines - adverse effects (284) 284
quinoxalines - adverse effects (282) 282
cessation (271) 271
bupropion - therapeutic use (269) 269
animals (256) 256
article (250) 250
efficacy (250) 250
neurosciences (250) 250
nicotinic agonists - adverse effects (249) 249
placebo (249) 249
aged (219) 219
medicine, general & internal (219) 219
tobacco use disorder - drug therapy (206) 206
nicotinic agonists - administration & dosage (205) 205
smoking - drug therapy (203) 203
young adult (203) 203
dependence (193) 193
benzazepines - administration & dosage (191) 191
quinoxalines - administration & dosage (188) 188
smoking prevention (187) 187
pharmacotherapy (184) 184
varenicline - therapeutic use (184) 184
analysis (181) 181
nicotinic agonists - pharmacology (180) 180
adolescent (176) 176
public, environmental & occupational health (175) 175
double-blind method (169) 169
smoking cessation - psychology (163) 163
cigarette-smoking (159) 159
drug therapy (159) 159
tobacco use cessation products (159) 159
abridged index medicus (155) 155
benzazepines - pharmacology (153) 153
nicotine - administration & dosage (152) 152
quinoxalines - pharmacology (151) 151
rats (150) 150
double-blind (145) 145
smoking - epidemiology (144) 144
care and treatment (141) 141
clinical trials (137) 137
research (137) 137
health aspects (136) 136
nicotine dependence (136) 136
dose-response relationship, drug (134) 134
smoking - psychology (134) 134
risk factors (129) 129
pharmacology (121) 121
abstinence (119) 119
smoking - adverse effects (117) 117
partial agonist (116) 116
addiction (115) 115
drug addiction (113) 113
counseling (112) 112
safety (111) 111
smoking - therapy (111) 111
therapy (111) 111
risk (108) 108
drugs (107) 107
schizophrenia (106) 106
nicotine - therapeutic use (102) 102
tobacco dependence (101) 101
alpha-4-beta-2 (98) 98
mortality (97) 97
time factors (97) 97
receptors, nicotinic - metabolism (95) 95
usa (93) 93
intervention (92) 92
smoking cessation products (91) 91
nicotine - pharmacology (86) 86
pharmacology/toxicology (86) 86
united states (85) 85
depression (84) 84
follow-up studies (84) 84
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2019) 2019
German (49) 49
Spanish (47) 47
French (30) 30
Japanese (9) 9
Czech (8) 8
Korean (6) 6
Polish (6) 6
Dutch (5) 5
Turkish (5) 5
Chinese (3) 3
Portuguese (3) 3
Swedish (3) 3
Danish (2) 2
Romanian (2) 2
Finnish (1) 1
Hungarian (1) 1
Italian (1) 1
Norwegian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


11/2010
Varenicline is used to treat tobacco dependence. While varenicline decreases craving during a quit attempt, no studies have investigated its effect on... 
varenicline | 0419 | cue-induced craving
Dissertation
Biological Psychiatry, ISSN 0006-3223, 2010, Volume 67, Issue 8, pp. 715 - 721
Background Cognitive alterations are a core symptom of nicotine withdrawal, contributing to smoking relapse. In rodents and humans, cognitive deficits can be... 
Psychiatry | varenicline | fMRI | nicotine | withdrawal | Addiction | cognition
Journal Article
Journal Article
Journal Article
11/2010
BACKGROUND: Alcohol and tobacco misuse and dependence are highly comorbid disorders. Varenicline alleviates symptoms of cigarette craving while preventing... 
Tobacco | Cue reactivity | 0572 | Varenicline | Alcohol | 0491
Dissertation
Biochemical Pharmacology, ISSN 0006-2952, 2009, Volume 78, Issue 7, pp. 813 - 824
Effects of the α4β2 nAChR partial agonist varenicline, an efficacious smoking cessation aid, in animal models of addiction, depression, cognition and... 
Depression | Cognition | Addiction | Varenicline | Nicotinic acetylcholine receptors
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 06/2007, Volume 29, Issue 6, pp. 1040 - 1056
Background: Varenicline, a selective α β nicotinic acetylcholine receptor partial agonist, has been developed specifically for smoking cessation. In Japan,... 
varenicline | smoking cessation | Japan | nicotinic partial agonist
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 05/2017, Volume 15, Issue 5.5, pp. 748 - 750
The harms of smoking cigarettes are well-known, and the benefits of smoking cessation are well-established. Smoking cessation is especially important for... 
ONCOLOGY | NICOTINE REPLACEMENT THERAPY | VARENICLINE
Journal Article
The Lancet Psychiatry, ISSN 2215-0366, 07/2019, Volume 6, Issue 7, pp. 563 - 564
Journal Article
Psycho-oncology, ISSN 1057-9249, 10/2017, Volume 26, Issue 10, pp. 1526 - 1534
Journal Article
Journal Article